- Home
- RYTM vs GHC Comparison
RYTM vs GHC Comparison
Compare RYTM & GHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RYTM
- GHC
- Stock Information
- Founded
- RYTM 2008
- GHC 1877
- Country
- RYTM United States
- GHC United States
- Employees
- RYTM N/A
- GHC N/A
- Industry
- RYTM Biotechnology: Pharmaceutical Preparations
- GHC Other Consumer Services
- Sector
- RYTM Health Care
- GHC Real Estate
- Exchange
- RYTM Nasdaq
- GHC Nasdaq
- Market Cap
- RYTM 3.8B
- GHC 4.0B
- IPO Year
- RYTM 2017
- GHC N/A
- Fundamental
- Price
- RYTM $61.74
- GHC $908.10
- Analyst Decision
- RYTM Strong Buy
- GHC
- Analyst Count
- RYTM 12
- GHC 0
- Target Price
- RYTM $74.92
- GHC N/A
- AVG Volume (30 Days)
- RYTM 940.6K
- GHC 30.2K
- Earning Date
- RYTM 05-06-2025
- GHC 04-30-2025
- Dividend Yield
- RYTM N/A
- GHC 0.79%
- EPS Growth
- RYTM N/A
- GHC 272.88
- EPS
- RYTM N/A
- GHC 163.40
- Revenue
- RYTM $130,126,000.00
- GHC $4,790,904,000.00
- Revenue This Year
- RYTM $43.84
- GHC $3.30
- Revenue Next Year
- RYTM $65.62
- GHC $6.10
- P/E Ratio
- RYTM N/A
- GHC $5.56
- Revenue Growth
- RYTM 68.06
- GHC 8.52
- 52 Week Low
- RYTM $35.17
- GHC $683.00
- 52 Week High
- RYTM $68.58
- GHC $1,003.53
- Technical
- Relative Strength Index (RSI)
- RYTM 61.94
- GHC 44.36
- Support Level
- RYTM $59.54
- GHC $877.00
- Resistance Level
- RYTM $62.83
- GHC $925.62
- Average True Range (ATR)
- RYTM 4.27
- GHC 29.14
- MACD
- RYTM 1.00
- GHC -3.38
- Stochastic Oscillator
- RYTM 92.04
- GHC 25.40
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.
About GHC Graham Holdings Company
Graham Holdings Co. is a diversified education and media company made up of subsidiaries. Firm operations include educational services; television broadcasting; online, print, and local news; home health and hospice care; and manufacturing. The Company segments into the following seven reportable segments: Kaplan International, Higher Education, Supplemental Education, Television Broadcasting, Manufacturing, Healthcare, and Automotive. The majority of revenue comes from the Kaplan International segment, which includes higher education, test preparation, language instruction, and professional training. A large portion of company revenue also comes from the television broadcasting segment through advertising.